BONE BIOLOGICS CORP (BBLG:NASDAQ)
$0.5508 -0.0102 (-1.8182%)
Analysed BONE BIOLOGICS CORP (BBLG:NASDAQ) News Sources
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
23-07-2026
yahoo.com
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
08-01-2026
yahoo.com
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
23-12-2025
yahoo.com
BBLG In Good Shape as Critical Tests Underway
15-05-2026
yahoo.com
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08-07-2026
yahoo.com
BBLG Secures Financing for Critical Trials
08-07-2026
yahoo.com
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
12-08-2026
yahoo.com
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances
12-08-2026
advfn.com
BBLG Efficiency Improves as Crucial Trials Advance
17-08-2026
yahoo.com
Bone Biologics Expands Trial Sites
08-09-2026
yahoo.com
What is the current price of BONE BIOLOGICS CORP (BBLG:NASDAQ)?
The current price of BONE BIOLOGICS CORP (BBLG:NASDAQ) is $0.5508.
BONE BIOLOGICS CORP (BBLG:NASDAQ) absolute price change since previous trading day?
The absolute price change of BONE BIOLOGICS CORP (BBLG:NASDAQ) since the previous trading day is $-0.0102.
BONE BIOLOGICS CORP (BBLG:NASDAQ) percentage price change since previous trading day?
The percentage price change of BONE BIOLOGICS CORP (BBLG:NASDAQ) since the previous trading day is -1.8182%.
What is the most recent average sentiment score for BONE BIOLOGICS CORP (BBLG:NASDAQ)?
The most recent average sentiment score for BONE BIOLOGICS CORP (BBLG:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for BONE BIOLOGICS CORP (BBLG:NASDAQ)?
The most recent sentiment for BONE BIOLOGICS CORP (BBLG:NASDAQ) is .
SEC-8K** Filing Available For BONE BIOLOGICS CORP (BBLG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.